The goals of this administrative supplement project are to undertake systematic evaluation of a subset of the protein capture reagents (antibodies) that have been generated by the NIH Common Fund Protein Capture Reagents Program (PCRP). Our goals are to: (1) validate each antibody by Western blot analysis; (2) evaluate each antibody by protein binding microarray (PBM) or other in vitro DNA binding assay; (3) perform computational motif enrichment analysis of antibodies assayed by ChIP-Seq or ChIP-exo in other PCRP labs; (4) generate a report file for each antibody from each validation assay. These biochemical validation assays will evaluate the ability of these antibodies to recognize their target transcription factors in solution and also when bound to DNA in vitro, while and the motif enrichment analysis will seek to provide support for the antibody detecting TF bound in vivo directly to its genomic target sites or potentially indirectly through co-regulatory factors. These validation assays will extend the utility of the PCRP capture reagents as a resource to the community by demonstrating the utility of the capture reagents to recognize transcription factors bound to DNA.

Public Health Relevance

In this project we will evaluate antibodies generated by the NIH Protein Capture Reagents Program (PCRP) for human transcription factors. The validated antibodies will allow for further characterization of this important class of regulatory factors.

Agency
National Institute of Health (NIH)
Institute
National Human Genome Research Institute (NHGRI)
Type
Exploratory/Developmental Grants (R21)
Project #
3R21HG009268-03S2
Application #
9966132
Study Section
Program Officer
Pazin, Michael J
Project Start
2019-08-06
Project End
2020-07-31
Budget Start
2019-08-06
Budget End
2020-07-31
Support Year
3
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
030811269
City
Boston
State
MA
Country
United States
Zip Code
02115